Tidal Vision: $140 Million (Series B) Raised For Scaling Chitosan Technologies
By Amit Chowdhry ● Feb 7, 2025
Tidal Vision, a biotechnology company transforming critical industries with chitosan-based chemistries, announced the closing of an oversubscribed $140 million Series B financing round. This funding round exceeded its original target due to demand from strategically investors including Cambridge Companies SPG, Eni Next (the corporate venture arm of Eni S.p.A), Milliken & Company, KIRKBI Climate, Convent Capital, SWEN Capital Partners' Blue Ocean Fund, MBX Capital, Oman Investment Authority's IDO Investments, and more.